Stock Scorecard
Stock Summary for Artivion Inc (AORT) - $20.93 as of 5/3/2024 8:24:31 PM EST
Total Score
5 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for AORT
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AORT
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AORT
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for AORT
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for AORT
Financial Details for AORT
Company Overview |
|
|---|---|
| Ticker | AORT |
| Company Name | Artivion Inc |
| Country | USA |
| Description | Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/14/2024 |
Stock Price History |
|
| Last Day Price | 20.93 |
| Last Day Price Updated | 5/3/2024 8:24:31 PM EST |
| Last Day Volume | 119,014 |
| Average Daily Volume | 163,950 |
| 52-Week High | 21.90 |
| 52-Week Low | 12.16 |
| Last Price to 52 Week Low | 72.12% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 47.09 |
| Sector PE | 55.58 |
| 5-Year Average PE | 5.77 |
| Free Cash Flow Ratio | 14.84 |
| Industry Free Cash Flow Ratio | 59.38 |
| Sector Free Cash Flow Ratio | 31.79 |
| Current Ratio Most Recent Quarter | 4.85 |
| Total Cash Per Share | 1.41 |
| Book Value Per Share Most Recent Quarter | 6.86 |
| Price to Book Ratio | 3.03 |
| Industry Price to Book Ratio | 5.21 |
| Sector Price to Book Ratio | 22.19 |
| Price to Sales Ratio Twelve Trailing Months | 2.41 |
| Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.15 |
Share Statistics |
|
| Total Shares Outstanding | 41,709,800 |
| Market Capitalization | 872,986,114 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 12/9/2015 |
| Last Dividend Amount | 0.03 |
| Current Dividend Amount | 0.03 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 2.13% |
| 3-Year Dividend Growth Rate Percentage | 5.65% |
| 5-Year Dividend Growth Rate Percentage | 33.89% |
| All-Time Dividend Growth Rate Percentage | 33.89% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -59.91% |
| Reported EPS 12 Trailing Months | -0.75 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -0.74 |
| Net Income Twelve Trailing Months | -30,690,000 |
| Net Income Past Year | -30,690,000 |
| Net Income Prior Year | -19,192,000 |
| Quarterly Revenue Growth YOY | 18.00% |
| 5-Year Revenue Growth | 4.72% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 58,940,000 |
| Total Cash Past Year | 58,940,000 |
| Total Cash Prior Year | 39,351,000 |
| Net Cash Position Most Recent Quarter | -248,042,000 |
| Net Cash Position Past Year | -248,042,000 |
| Long Term Debt Past Year | 306,982,000 |
| Long Term Debt Prior Year | 308,107,000 |
| Total Debt Most Recent Quarter | 306,982,000 |
| Equity to Debt Ratio Past Year | 0.48 |
| Equity to Debt Ratio Most Recent Quarter | 0.48 |
| Total Stockholder Equity Past Year | 281,780,000 |
| Total Stockholder Equity Prior Year | 284,329,000 |
| Total Stockholder Equity Most Recent Quarter | 281,780,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.02 |
| MACD Signal | 0.06 |
| 20-Day Bollinger Lower Band | 16.15 |
| 20-Day Bollinger Middle Band | 19.13 |
| 20-Day Bollinger Upper Band | 22.10 |
| Beta | 1.66 |
| RSI | 51.48 |
| 50-Day SMA | 16.95 |
| 200-Day SMA | 19.08 |
System |
|
| Modified | 5/3/2024 5:35:38 PM EST |